紧随强生,波士顿科学杀入这一领域

医疗器械创新网
09 Jan

2025年1月8日,波士顿科学公司(NYSE: BSX)正式宣布,已同意收购血管内碎石术(Intravascular Lithotripsy, IVL)器械公司Bolt Medical。该交易以100%股权为基础,前期估值为6亿美元。此外,在达到某些监管里程碑后,波士顿科学还将最高额外支付3亿美元。此次交易标志着波士顿科学正式进军热门的IVL(血管内碎石术)领域。01Bolt Medical:创新...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10